Phase I/II Study of PRO044 in Duchenne Muscular Dystrophy (DMD)
Clinical trial NCT01037309 · COMPLETED
Trial details
- NCT number
- NCT01037309
- Sponsor
- BioMarin Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2013-05-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.